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Abstract 
Indiscriminate use of antibiotics has created a selective advantage for resistant 
strains of bacteria. Resistance is spread through bacterial conjugation, whereby plasmids 
that contain genes for alternate enzymes are transmitted directly between bacteria. The R-
plasmid encoded enzyme R67 dihydrofolate reductase (DHFR) confers resistance to the 
antibacterial drug trimethoprim. Typically, chemical screening for new drugs involves 
modification of the known ligands for a given enzyme. On the other hand, novel 
structures can be identified through computer screening. The program suite DOCK 
developed by Irwin Kuntz, et al. at UCSF docks ligands into an enzyme of known 
structure based on Van der Waals interactions. First, the program, MS, developed by 
Michael Connolly, creates a surface by calculating the solvent accessible surface over the 
crystal structure (obtained from the Protein Data Bank). Then SPHGEN fills the 
invaginations of the active site with a set of overlapping spheres. A negative image of the 
site is created from the set of sphere centers. The ligand interactions are evaluated by 
constructing a grid over the protein structure using GRID. Ligands from the Cambridge 
Structural Databank (CSD) were scored for Van der Waals interactions with R67 using 
DOCK and the top 1000 scoring molecules were run again considering more orientations. 
The top scoring compounds were identified for testing in the laboratory as potential 
inhibitors of R67 DHFR. 
Introduction 
Antibiotic Resistance 
In 1929, Alexander Fleming discovered penicillin, the first antibiotic. Initial 
optimism about the universal efficacy of antibiotics led to their overuse. Antibiotics are 
used as a common addition to animal feed, in order to expedite their marketability. The 
indiscriminate use of antibiotics has resulted in a selective advantage for bacterial 
resistance. High levels of resistance usually indicate the presence of a Resistance plasmid 
or R-plasmid. Resistance plasmids are spread through the phenomenon of bacterial 
conjugation, which involves the transfer of genetic material. Though it is impossible to 
determine when these plasmids first evolved, there is evidence to suggest that they 
predate the use of antibiotics. For example, resistance plasmids have been found in non-
pathogenic soil bacteria. A selective pressure may have existed in the soil because many 
antimicrobial agents such as penicillin are soil organisms. Also a strain of E. coli that was 
frozen in 1946, was found to contain plasmids conferring resistance to tetracycline and 
streptomycin. Neither drug was used clinically until many years later. Thus the 
indiscriminate use of antibiotics has not sped the evolution of novel resistance 
mechanisms, but has simply created a selective advantage for the transmission of the R-
plasmids. R-plasmids contain genes that code for new proteins that either inactivate the 
antibacterial drug, actively pump it out of the cell, or simply prevent its uptake. Once 
these proteins are identified they become the targets for new drugs. 
Traditional drug screening involves modification of the known ligands through 
the addition or removal of functional groups. Though effective, this mechanism feeds the 
evolution of the enzymes through mutation of the residues that interact with the ligands. 
Inhibitors developed in this manner do not require a complete overhaul of the enzyme 
structure to be rendered ineffective. Thus, it becomes a race between the development of 
mutations within the bacteria, and the development of new drugs by the researcher (1). 
A Resistance Enzyme: R67 Dihydrofolate Reductase 
The enzyme dihydrofolate reductase (DHFR) converts dihydrofolate (DHF) to 
tetrahydrofolate using nicotinamide adenine dinucleotide phosphate (NADPH) as a 
cofactor. It thus replenishes folate cofactors required for nucleotide synthesis (2). The 
chromosomal enzyme is inhibited by trimethoprim, an antibiotic administered with 
sulfonamides. R67 dihydrofolate reductase, an R-plasmid encoded protein, bears no 
homology to the chromosomal DHFR either in sequence or structure. Thus it confers 
resistance to the antibiotic. 
R67 DHFR is a roughly doughnut shaped homotetramer 30 x 35 x 40 A3 (Figure 
1). A 25 A pore with 2,2,2 symmetry is found along the length of the molecule (3). The 
active site pore narrows to 12 A x 9 A in the center. Since R67 is a homotetramer, four 
identical folate binding sites are expected. However, for steric reasons, only two ligands 
are able to bind asymmetrically to symmetry-related binding sites (4). R67 DHFR will 
bind either two folate molecules or two NADPH molecules in an unproductive complex 
or one NADPH plus one folate in a productive complex. However, the binding of 
NADPH inhibits the binding of a second NADPH molecule and thus facilitates the 
binding of DHF to form a productive complex. There is no evidence of an induced-fit 
mechanism in the binding of the ligands. Thus, R67 DHFR is a good choice for the rigid 
approximation of a computational binding study. 
The DOCK Program Suite 
The DOCK program suite characterizes the active site of the enzyme of interest, 
matches potential ligand molecules to that site, and then scores the complementarity of 
the ligand to the active site (5)(6). As input, DOCK requires crystal structures of the 
protein and ligand molecules, and a molecular surface file generated by Michael 
Connolly's program Molecular Surface (MS). 
Figure 1: R67 DHFR with Folate (bound) and NADP+ (docked). 
MS estimates the solvent accessible surface of the receptor by rolling a water 
molecule over the surface of the protein (7). The first DOCK program, SPHGEN, then 
estimates the grooves and invaginations of this surface with a set of overlapping spheres. 
It then groups these spheres into clusters. This creates a negative image of the active site 
(8). Next, a scoring grid is created from the original receptor file with the program GRID 
to provide a means of evaluating ligand complementarity. DOCK compares the structures 
of the potential ligands to the image of the active site by comparing internal distances 
based on van der Waals radii. This is known as contact scoring. The number of 
orientations to be tried, and other input parameters, are specified in the dock.in file. In 
addition, to contact scoring, DOCK is able to take into account chemical 
complementarity, flexibility of ligand and receptor, energetic considerations, and 
electrostatic interactions with the solvent and receptor molecule. With these 
considerations, DOCK is able to provide more accurate predictions of ligand interactions 
(9). 
DOCK can be used to analyze the interaction of a known or potential ligand in 
detail, or it can be used to screen a database of molecules for potential drug targets. The 
following assumptions are made in the latter case: the receptor and ligands are rigid, 
water and counter-ions are neglected, interaction energies are simplified. Computing time 
increases enormously with the incorporation of these factors, therefore it is impractical to 
consider them While screening a large number of molecules (8). 
The Role of Electrostatics 
Electrostatic interactions are known to play an important role in the binding of 
ligands to the chromosomal DHFR in E.coli. The molecule carries a net charge of -10, 
yet it binds NADPH and folate, both of which have net negative charges. An analysis of 
the electrostatic charge distribution revealed a positive charge distribution at the active 
site. This is thought to be a result of the presence of positively charged residues at the 
entrance to the ligand binding site (10). Electrostatic potential is calculated with the 
Finite Poisson Boltzmann Method. 
R67 DHFR has an overall neutral charge and binds negative ligands, analysis of 
the electrostatic charge distribution could help elucidate the mechanism of ligand 
binding. Also, the charge distribution should be taken into account while identifying 
potential ligands for docking. 
The program DelPhi, developed by Barry Honig, is a finite Poisson Boltzmann 
difference solver (11). It takes not only charge interactions within the macromolecule into 
consideration, but also the interaction of those charges with the solvent. The presence of a 
charged residue on the surface of the molecule induces a dipole moment onto nearby 
solvent molecules. This induced dipole is strongest near the point charge, and decreases 
with distance. The induced dipole of the solvent serves to connect areas of similar 
potential. 
To visualize this, DelPhi generates a potential map that can be viewed with the 
molecular modeling software Insight (Biosym Technologies, San Diego, CA), in which 
red is negative, white neutral, and blue positive (12). Analysis of electrostatic potential 
can refine a docking search by eliminating molecules with inhibited binding. 
Materials and Methods. 
All programs were run on a Silicon Graphics Indigoll computer (Silicon 
Graphics, Inc. Mountain View, CA). A step by step protocol is included in Appendix 1. 
Preparation of Ligand Files 
Potential ligand molecules from Cambridge Structural Database (13) were 
screened using Quest to exclude organometallic compounds. The remaining 20,000 
molecules were saved as a * .mol2 format file. 
Preparation of the Receptor 
Docked ligands and crystallographic waters were removed from the Protein 
Databank (PDB) format receptor file in Insight. The PDB file was then run through MS, 
by a DOCK accessory program called AUTOMS. Unnecessary parts of the molecule 
were saved as an exclude.pdb file using another modeling program called Sybyl (Tripos, 
Inc. St. Louis, MO). The output MS file was fed into SPHGEN. SPHGEN parameters 
were specified in a file called INSPH (see appendix). Sphgen results were viewed using 
the DOCK accessory program, SHOWSPHERE. 
Unwanted sphere clusters were deleted by hand in Sybyl, and the results were 
saved as a *.sph file using PDBTOSPH. Next, a scoring grid was created using GRID. 
Input parameters for GRID were specified in a file called grid.in. Grid results were 
viewed using SHOWBOX. 
DOCK 
DOCK input parameters were specified in dock.in file (see appendix). 
Compounds from the CSD were then docked with R67. Fifty orientations were scored for 
each crystal structure. The top 1000 scoring compounds were rerun considering 400 
orientations. 
For a more realistic model of ligand binding, a new Sphere file was created with 
the crystallographic waters intact. Molecules from the CSD were then docked with this 
new sphere cluster. Also, a mol2 file of NADP+ and of folate were created in INSIGHT 
and docked with R67 as a basis for comparison. The NADP+ and folate coordinates were 
obtained from the chromosomal DHFR structure. 
Results were viewed by dividing the output files into manageable portions, and 
viewing them in INSIGHT referenced to the R67 molecule (14). The top scoring 
molecules were alphabetized using a program written by Rod Bunn (15), to create a 
reference code list that could be viewed in the Cambridge Structural Database. 
DelPhi Electrostatics 
Electrostatic Potential Maps were created using DelPhi. The default charge and 
size files obtained with the program were used. The influence of Lysine residues on the 
electrostatic potential in the pore was then analyzed by removing the charge for the 
amino acid in the charge file and viewing the resulting potential map. The process was 
repeated for Histidine and Arginine. Alternatively, individuallysines were mutated on 
the computer and replaced by methionine residues. 
Results and Discussion 
SPHGEN 
The negative image created with SPHGEN reflects the active site symmetry of 
R67 (Figures 2 & 3). Viewed from the front, the pore appears split into four chambers. 
When viewed from the side the negative surface looks like two flattened cones oriented 
perpendicular to one another (Figure 4). The negative surface provides a means of 
visualizing the asymmetric binding of the ligands. Also, it is clear that only two ligands 
can bind due to the van der Waals interactions between residues in the pore. 
DOCK 
Some difficulties were encountered while running GRID. It proved complicated 
to limit the size of the scoring grid to only the active site of the enzyme. This may have 
contributed to the length of time required to run DOCK. 
Due to computational constraints, the number of heavy atoms in the ligand 
molecules was limited to 50. This is unrealistic, since folate and NADP+ possess 60-70 
heavy atoms. 
The top scoring compound BZANTClO scored at -210. In comparison, folate, 
which was scored for 400 orientations scored -106, and NADP+ scored -149. Many of 
the compounds scored higher than the natural ligands, based on a comparison distances to 
residues in the active site pore. 
DOCK identified many modified purines and pyrimidines (Figures 5& 6). These 
results were not surprising, since purines and pyrimidines are similar in structure to the 
natural ligands. However, DOCK also identified compounds of novel structure such as a 
crown ether (Figure 7). Upon viewing the compounds in the CSD, many were too 


Figure 4: Sphere Clusters Viewed Along the Length of the Molecule 
Figure 5: 3',5'-Oi-O-acetyl thymidine docked with R6? OHFR 
Figure 6: Deoxycholic Acid (co-crystallized with salicylic acid) 
docked with R67 DHFR 
Figure 7: 15-crown-5-clathrate docked with R67 DHFR 
hydrophobic to interact with R67 in solution, or were toxic and thus had to be eliminated 
as potential candidates for inhibition. Mr. J. Helton screened the kinetic effect of 15-
crown-5 clathrate, 3' -azido-3' -deoxythymidine,deoxycholic acid, 1,4,5 ,8-naphthalene 
tetracarboxylic anhydride, and 3' ,5' -di-O-acetyl thymidine on the activity of DHFR (16). 
DelPhi Potential Maps 
The potential map generated by DelPhi showed a concentration of positive charge 
in the active site pore. Since there are no positive residues in the pore itself, the influence 
of the lysine residues near the pore was analyzed. When the charge on all eight symmetry 
related lysines (residues 32 and 33) is removed, the active site pore becomes red colored 
(negatively charged). Thus, the presence of the Lysines is essential to the observed 
charge distribution. To analyze the individual contribution of each Lysine, they were then 
treated separately. When lysine 33 is removed, the charge becomes more concentrated in 
the pore. This is logical since lysine 32 is physically closer to the pore. However, when 
the charge on Lysine 32 is removed, a blue area is still observed in the pore. This is due 
to the presence of Histidine 62. When the charge on Histidine is removed in addition to 
that on Lysine 32, the blue in the pore disappears (Figure 8). Interestingly, the Arginines, 
though far removed from the pore, influence the charge distribution as well. When their 
charge is removed, the active site becomes neutral (white). Since they are on the outside 
or the molecule, they have a greater influence on the induced dipoles in the solvent. 
Additionally, arginines tend to be more exposed to solvent. 


Future Studies 
The Heavy Atom limit can be circumvented by dividing the database into small 
portions. This is currently being done in the lab, and should result in more accurate 
predictions. Some predicted compounds were also tested for inhibition (16). Lysine and 
Histidine mutants were created in the lab. Kinetic studies should be done on these 
mutants to determine the accuracy of the DelPhi predictions. Electrostatic considerations 
should be incorporated into DOCK, as well as energy scoring and chemical matching. 
Also, it is unrealistic to assume that the ligands are rigid. Use of the flexible ligand model 
within DOCK should yield a more realistic representation of ligand binding. 
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Appendix 1 
Protocol for DOCK 
Protocol for DOCK 
A step by step guide for searching for potential ligands 
Ingredients: A Siilcon Graphics Machine 
and ... 
Insight 
SYBYL 
DOCK 
MS 
The Cambridge Structural Databank 
Delphi 
A researcher, 
A computer guy, 
A student (to do things like type up this protocol) © 
To run dock, we must start with a receptor file from the protein databank. The first step is 
to remove any ligands that were co-crystallized and to remove crystallographic waters. 
(do this in INSIGHT) 
r67 without ligands and waters lusr/people/ushmalnarayanaternaryl.pdb 
r67 with ligands lusr/people/ushmalnarayanaternary2.pdb 
r67 with waters lusr/people/ushmalnarayanaternary3.pdb 
r67 with ligands and waters lusr/people/ushmalnarayanaternary4.pdb 
Next we must create a Connolly surface using the program MS (molecular surface) from 
the QPCE (Quantum Program Chemistry Exchange). 
go to lusr/people/ushmalconollysurf 
Dock will automatically run MS and create at dock input file using the program AutoMS. 
However AutoMS has a fatal program error. A corrected copy of the program is included 
with MS. The file is called DOCK_interface(Cf:IECKPA'JlN). We can find the 
differences between the two programs with the unix difference command: 
$diff DOCK_interface lusr/datalushmaldock4lbinlautoMS 
Using jot, we then update the paths in the DOCK_interface file and take off the header. 
save as autoMS. 
dock_root= lusr/datalushmaldock4lbin 
MS_executable= lusr/people/ushmalconnollysurf/429 _sgrw/connolly 
(AutoMS requires an extract.pdb file to run.) 
First we must exclude all portions of the molecule that are irrelevant to our search. We do 
by creating an exclude.pdb file using the molecular modeling program SYBYL. We use 
SYBYL remotely on Dr. Baker's machine in the Chemistry Department. To go to Dr. 
Bakers machine: 
$xhost + 
$telnet sugar.chem.utk.edu 
login: howell 
password: folate 1 
$sybyl 
This will bring up the SYBYL program. 
Under the file tab select read 
Select the desired pdb file (see sybyl files list) 
When asked if the molecule should be centered, select yes. 
In order to create a shell that encompasses a spherical or symmetrical active site, we must 
add a raw atom to the center of the active site. Select C3. 
For the coordinates enter (0,0,0) since we want the molecule in the center of the active 
site. 
Go the extract command 
When prompted to select atoms select the center atom we added by clicking on it. 
Then hit the sets tab on the extract command window. Select sphere. 
Enter a radius of 15 angstroms. (Adjust this to include whatever parts of the molecule are 
of interest). 
Then hit the invert tab. It will ask where you wish to put the extracted atoms. Put them in 
M2 (molecular area two). Save M2 as a Brookhaven file called exclude.pdb (Be sure to 
rename any old exclude.pdb files you may want to keep). 
Use xftp to move the files from sugar to how2.bio.utk.edu. Put in 
lusrl datalushmal dock4/bin 
Log off of Dr. Baker's machine. Look at the created file in INSIGHT. 
$cd lusr/datalushmaldock4/bin 
$autoMS lusr/people/ushmalnarayanaternary 1. pdb 
• location of receptor pdb file 
The output file should have the extension * .ms. 
The screen should read: Ready to run SPHGEN 
Now we must create an INSPH File! Using jot, type the following (excluding the parts in 
parentheses). Modify as needed. For an explanation of the values see the DOCK manual 
p.84. 
/usr/people/ushma/narayanatemaryl.ms (~MS output file) 
R 
X 
0.0 
4.0 
/usr/people/ushma/narayanatemary1.sph (~ Sphgen output file name) 
$sphgen 
It takes a while to run, so this is a good time for a snack. © 
The OUTS PH file contains useful information including the number of sphere clusters 
generated. 
density type = X 
reading /usr/people/ushma/narayanatemary3.ms 
# of atoms = 2000 # of surf pts = 21996 
finding spheres for /usr/people/ushma /narayanatemaryl.ms 
dotlim = 0.000 
radmax = 4.000 
Minimum radius of acceptable spheres? 
1.400000 
output to /usr/people/ushma/narayanatemary 1.sph 
clustering is complete 27 clusters 
There are probably more sphere clusters thatn you need. We can visualize the sphere 
clusters using the program showsphere. It is interactive. 
$showsphere 
the input is as follows: 
/usr/people/ushma/narayanatemary 1.sph 
o 
n 
/usr/people/ushma/showsphere. pdb 
Transfer the created showsphere file to Dr. Baker's machine so that it can be viewed with 
SYBYL. 
Unwanted Spheres must be removed by hand. Choose the EXTRACT command, click 
on atoms, then sets, choose sphere with a radius of 1-3 angstroms. Invert. Save as another 
molecule (Ml or M2 whichever is unoccupied). Now zap the first Molecular area. The 
second area now contains the molecule minus the selected sphere clusters. Repeat this 
process until all unwanted clusters have been removed. Rinse Gust kidding). Save the 
number cluster file with an appropriate name (eg. reducedsph.pdb). 
FrP the new file back to how2.bio.utk.edu. Place in 
/usr/ datalushmaldock4lbin/( filename). 
Run pdb to sph to change the file into the sphere format required by dock 
$pdbtosph 
input file: 
output file: 
reducedsph. pdb 
reducedsph.sph 
Next we must create a scoring grid, using GRID. 
See p.80 of the Dock reference manual. 
Read the receptor file into INSIGHT, Set the potentials, add H's, and charges. Modify the 
hydrogens and fix forcefield potentials. Using Molecule/put save the receptor as a mo12 
file. (this takes a while to save) 
Run using created box file box.pdb . The following is sample input for GRID. 
compute_grids 
outpucmolecule 
grid_spacing 
contacCscore 
contacCcutofCdistance 
chemicaLscore 
energy_score 
bump_filter 
bump_overlap 
receptocfile 
box_file 
vdw _definition_file 
score_grid_prefix 
yes 
no 
0.3 
yes 
4.5 
no 
no 
yes 
0.75 
lusr/people/ushmalnarayanaternary l.mol2 
/usr/ datalushmal doc4lbinlbox. pdb 
lusr/datalushmaldock4/parameter/vdw.defn 
grid2 
The Grid Command line is $grid -i grid.in 
GRID takes a really long time to run and the output file size is quite large. 
Look at the GRID output using showbox. This is also an interactive program. 
The output when viewed in Insight, should encompass all areas of the molecule that are 
of interest. Reference the grid file to the receptor file for comparison. 
(Yes, it's supposed to be a boring yellow box) 
PREP~RE LIGi\:NDFILE in Cambridge. 
$cd /usr/dataiCAMBRIDGE 
$setenv CSDHOME 'pwd' 
$set path = ($CSDHOMElbin Spath) 
$rehash 
$cd trials 
$ls 
$quest trialx (where x is the next number after the last trial in this directory) 
$term x 
$menu 
The x-windows version of Cambridge should appear. Click in the window to begin. Go to 
the TO SEARCH tab in the upper right hand corner. Choose NUMERICAL. Go to 
CLASS enter RANGE and enter 1-64. Then return to the main menu. Save as mol2 and 
as REFCODE LIST. Go to the QUEST ... command and selected the 1-64 search and hit 
ONLY ORGANICS. Then hit startsearch. When the first result comes up, click DIAG 
with the right mouse button (this speeds up anything done with the left mouse button). 
The compounds should flash on the screen very rapidly. (This is neat to watch, but takes 
a couple of hours). At the end, the message End of Database Encountered! comes up and 
you are asked if you want to quit. Say yes. Once you are out of Cambridge check to see 
that a trialx.mo12 and a trialx.gcd file have been created, by using the unix list command: 
$ls This mo12 file will be the ligands file for DOCK. 
Now we are (finally) ready to run DOCK!!! (a dance of joy may be appropriate) 
First we must create an dock.in file. 
here is a sample file: 
flexible_ligand 
orienCligand 
score_ligand 
minimize_ligand 
multiple_ligands 
parallel.Jobs 
random_seed 
match_receptocsites 
random_search 
automated_matching 
maximum_orientations 
write_orientations 
rank_orientations 
rank_orientations_total 
intermolecular_score 
gridded_score 
grid_version 
bump_filter 
bump_maximum 
contacCscore 
chemical_score 
energy_score 
no 
yes 
yes 
no 
no 
no 
o 
yes 
no 
yes 
50 
yes 
yes 
10 
yes 
yes 
4 
yes 
3 
yes 
no 
no 
atom_model 
vdw_scale 
electrostatic_scale 
ligands _maximum 
intial_skip 
interval_skip 
heavy _atoms_minimum 
heavy _atoms_maximum 
rank_ligands 
rank_ligands_total 
restart_interval 
ligand_atom_file 
receptor_site_file 
score_grid_prefix 
vdw _definition_file 
quicfile 
dump_file 
info_file 
restart_file 
manual) 
contacC clash_penalty 
ligand_contacCfile 
ligand_centers 
The DOCK command line is: 
$dock -i dock.in 
u 
1 
1 
20000 (note: this number must be larger than the 
total number of molecules in the ligands file) 
o 
o 
4 
40 (this limits the time that the run takes) 
yes 
1000 
100 
lusr/datalCAMBRIDGE/trials/trial2.mol2 
(change this to subset) 
lusr/people/ushmalnarayanaternary3. sph 
grid3 
lusr/datalushmal dock4/parameter/vdw .defn 
(this file is provided with dock. The path MUST be correct) 
docklS.quit 
docklS.dump 
docklS.info 
docklS.rst (restart commands are in the DOCK 
SO 
dock_cnt1S.moI2 (this is the results file) 
no 
This gives the top 1000 scoring ligands. We then reran these thousand with more 
orientations. 
These parameters have to be changed: 
maximum_orientations 400 
ligands_maximum 1000 
To view the results: 
First, convert the dock.info (save to disk and move to the Gateway Computer) file to a 
REFCODE list for Cambridge, using Rod's program. 
Click on DOCK_converter 
Go to Filel Alpha 
Put source file name in source Box. 
Then Select files and save conversions 
It should read finished when its done. 
save file as trialx.gcd 
$cd lusr/dataJCAMBRIDGE 
$setenv CSDHOME 'pwd' 
$set path = ($CSDHOMElbin $path) 
$rehash 
$cd trials 
$setenv CSDVIRTDB trialx.gcd 
$quest trial(x+l) 
At this point you should see information about the Cambridge Strucutural Databank flash 
acroos the screen. 
Near the top it should say: search being run on VIRTDB trialx 
(this greatly speeds up the viewing process) 
$term x 
$menu 
[to remove the virtual database option, type unsetenv CSVIRTDB] 
Now the x-windows version of CSD appears. Click in the window to begin. 
In the upper right hand corner, click on TO SEARCH 
From the search options choose TEXT 
From the text options choose REFCODE 
Enter the reference codes (eg. BZANTC 10) one by one for the compounds that you wish 
to view. 
When you are done return to the main menu. 
Go to the QUEST ... option. You should see a REFCODE list. Choose only organics on 
the right side's menu. Select 1 of the refcodes listed. Then hit SEARCH. The selected 
compounds will appear on the screen. Go to view ID to see the compounds chemical 
name. 
Hit reject from the 2D/3D option. It will then tell you: End of Database Encountered! Do 
you wish to exit? If you do not exit at this point you will lose all hits from this search! 
Enter no. (This is a flaw in the program. There must be a way to save the compounds that 
you like from the reference list, but I haven't been able to do it without getting this 
message.) 
Then repeat with each of the compounds of interest. 
When you are ready to exit Cambridge, go to the exit option on the main menu. 
To view the results oriented to the receptor: 
$cd lusr/dataJushmaJdock4lbin 
The dock_cnt.moI2 files are too big to open!!! Split them up using the program from 
Tina Yeh at Biosym. 
See Media.Mail forinstructions 
The program is in lusr/dataJushmaJdockrunl called renamefiles. 
$mkdir lusr/dataJushmaJdockrunx 
$ cp lusrl dataJushmaJdockrun l/renamefiles lusrl dataJushmaJ dockrunxlrenamefiles 
$cp lusr/dataJushmaJdock4lbinidock_cntx.moI2 
lusr/dataJushmaJdock4/dockrunx/dock_cntx.moI2 
Now we have to change the access mode to the new folder. 
$chmod -R u+rwx /usr/dataJushmaJdockrunx 
$csplit -f dock_cnCnew dock_cntx.mo12 '!Number :/" { 49} , 
• (six spaces) 
$renamefiles dock_cnCnew .mol2 
jot to open and check files for refcodes of interest. 
Go into Insight. Molecule-7get-7 narayanatemaryl.pdb 
Get the compounds of interest from /usr/datalushmaldockrunx 
Pull them up while referencing the receptor molecule. 
Save images if desired. 
Delphi Electrostatics 
To create the delphi potential map: 
$ cd /usr/dataldelphilexport 
The charge file and parameter file must be modified. 
$cd /usr/dataldelphi/export/examples/SOD 
$ls 
$jot r67.prm 
An example parameter file: 
scale=O.8 
perfil=80 
in (pdb, file= "/usr/people/ushmalnarayanatemaryl.pdb") 
in (crg, file="examples/SOD/r67.crg") 
in (siz, file="examples/SOD/sod.siz") 
out (modpdb, file="r67 _delphi.pdb") 
out (phi, file="r67 .grd", form="BIOSYM") 
energy (c,s) 
Change the parameter file. Make sure that the output file extension is * .grd, so that it can 
be viewed with Insight. The size (*.siz) file is based on Van der Waals Radii and does not 
need to be modified. 
The charge file should be adapted for the molecule of interest. 
Go back to (*crg) /usr/dataldelphi/export 
The command line of Delphi is as follows: 
$delphi examples/SOD/parameterfile.prm > logfile.log 
[look at the logfile to make sure it ran] 
Viewing the results: 
Enter Insight. Pull up receptor molecule with Molecule/ get. Use Molecule/color to 
change backbone color to gray or white. The go to the third icon on the left side of the 
screen and click. Pull in * .grd file from /usr/dataldelphilexport . A yellow box should 
appear. Then graphically create a connolly surface by going to Molecule/Surface. Select 
low resolution or it will take Y2 hour to load. To Color the surface go to Molecule/Color. 
Under attribute choose surface. Under Color Method choose grid. Under Spectrum Name 
choose Delphi_Spectrum. This will display the potential map. 
